|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/415 | |
| C07D 233/60 | |||
| C07D 403/04 | |||
| C07D 417/12 | |||
| C07D 417/14 | |||
| C07D 263/32 | |||
| C07D 277/24 | |||
| C07D 277/42 | |||
| A61P 35/00 | |||
| C07D 403/12 | |||
| C07D 417/04 |
| (11) | Number of the document | 2608671 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11820603.6 |
| Date of filing the European patent application | 2011-08-24 | |
| (97) | Date of publication of the European application | 2013-07-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/048980 |
| Date | 2011-08-24 |
| (87) | Number | WO 2012/027481 |
| Date | 2012-03-01 |
| (30) | Number | Date | Country code |
| 376675 P | 2010-08-24 | US | |
| PCT/US2010/0624 | 2010-12-29 | WO |
| (72) |
DALTON, James, T., US
MILLER, Duane, D., US
LI, Chien-Ming, US
AHN, Sunjoo, US
LU, Yan, US
WANG, Zhao, US
CHEN, Jianjun, US
LI, Wei, US
DUKE, Charles, US
|
| (73) |
Gtx, Inc.,
175 Toyota Plaza 7th Floor, Memphis, TN 38103,
US
University of Tennessee Research Foundation, UT Conference Center Suite 211 600 Henley Street, Knoxville, TN 37996-4122, US |
| (54) | COMPOUNDS FOR TREATMENT OF CANCER |
| COMPOUNDS FOR TREATMENT OF CANCER |